- Home
- TENX vs BOF Comparison
TENX vs BOF Comparison
Compare TENX & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TENX
- BOF
- Stock Information
- Founded
- TENX 1967
- BOF 2017
- Country
- TENX United States
- BOF United States
- Employees
- TENX N/A
- BOF N/A
- Industry
- TENX Biotechnology: Pharmaceutical Preparations
- BOF Packaged Foods
- Sector
- TENX Health Care
- BOF Consumer Staples
- Exchange
- TENX Nasdaq
- BOF Nasdaq
- Market Cap
- TENX 27.3M
- BOF 27.6M
- IPO Year
- TENX N/A
- BOF 2023
- Fundamental
- Price
- TENX $7.34
- BOF $3.24
- Analyst Decision
- TENX Strong Buy
- BOF
- Analyst Count
- TENX 3
- BOF 0
- Target Price
- TENX $16.67
- BOF N/A
- AVG Volume (30 Days)
- TENX 96.6K
- BOF 3.7M
- Earning Date
- TENX 11-14-2025
- BOF 11-13-2025
- Dividend Yield
- TENX N/A
- BOF N/A
- EPS Growth
- TENX N/A
- BOF N/A
- EPS
- TENX N/A
- BOF N/A
- Revenue
- TENX N/A
- BOF $10,179,595.00
- Revenue This Year
- TENX N/A
- BOF N/A
- Revenue Next Year
- TENX N/A
- BOF N/A
- P/E Ratio
- TENX N/A
- BOF N/A
- Revenue Growth
- TENX N/A
- BOF 95.18
- 52 Week Low
- TENX $4.32
- BOF $1.52
- 52 Week High
- TENX $8.24
- BOF $3.37
- Technical
- Relative Strength Index (RSI)
- TENX 54.72
- BOF 74.92
- Support Level
- TENX $7.00
- BOF $2.00
- Resistance Level
- TENX $7.72
- BOF $3.06
- Average True Range (ATR)
- TENX 0.49
- BOF 0.27
- MACD
- TENX -0.02
- BOF 0.10
- Stochastic Oscillator
- TENX 75.12
- BOF 90.51
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.